Proteomics

Dataset Information

0

SILAC-based quantitative proteomics analysis of lung cancer cells treated with a DNMTi drug decitabine


ABSTRACT: DNA methyltransferase inhibitors (DNMTi) has been shown to modulate pathways related to antigen processing/presentation, human leukocyte antigens (HLA), and interferon responses across different cancer types on the transcriptomic level (Li et al., 2014; Wrangle et al., 2013). Nevertheless, these transcriptomic changes may not fully reflect the alterations of surface proteins that provoke susceptibility to immunotherapy. Thus, we sought to obtain a comprehensive profile of surface proteins altered by decitabine (DAC) through isolating cell surface proteins from A549 human lung cancer cells before and after DAC treatment using EZ-link Sulfo-NHS-SS-Biotin-assisted biotinylation method, followed by SILAC-based quantitative proteomics approach.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Hsing-Chen Tsai  

PROVIDER: MSV000084997 | MassIVE | Fri Feb 21 11:03:00 GMT 2020

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-03-31 | GSE176144 | GEO
| PRJEB7907 | ENA
2020-10-29 | GSE140892 | GEO
2021-10-29 | GSE173797 | GEO
2014-03-12 | E-GEOD-55805 | biostudies-arrayexpress
| PRJNA433383 | ENA
2014-03-12 | GSE55805 | GEO
2024-05-31 | GSE224642 | GEO
| PRJEB53879 | ENA
| PRJNA721984 | ENA